<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Lambert–Eaton myasthenic syndrome - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Lambert–Eaton_myasthenic_syndrome","wgTitle":"Lambert–Eaton myasthenic syndrome","wgCurRevisionId":668464507,"wgRevisionId":668464507,"wgArticleId":18628,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Good articles","Articles with contributors link","Articles that use a Medicine navs subtemplate","Myoneural junction and neuromuscular diseases","Paraneoplastic syndromes","Autoimmune diseases","Syndromes"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Lambert–Eaton_myasthenic_syndrome","wgRelevantArticleId":18628,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Lambert–Eaton_syndrome","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Synapse_diag4.png/100px-Synapse_diag4.png","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome","wgWikibaseItemId":"Q1756898"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Lambert–Eaton_myasthenic_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-good-star" class="mw-indicator"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Lambert–Eaton myasthenic syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Lambert%E2%80%93Eaton_syndrome&amp;redirect=no" title="Lambert–Eaton syndrome">Lambert–Eaton syndrome</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Lambert–Eaton myasthenic syndrome</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Synapse_diag4.png" class="image"><img alt="Synapse diag4.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Synapse_diag4.png/230px-Synapse_diag4.png" width="230" height="209" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Synapse_diag4.png/345px-Synapse_diag4.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Synapse_diag4.png/460px-Synapse_diag4.png 2x" data-file-width="627" data-file-height="571" /></a>
<div>Neuromuscular junction. Lambert–Eaton myasthenic syndrome is caused by autoantibodies to the presynaptic membrane. Myasthenia gravis is caused by autoantibodies to the postsynaptic acetylcholine receptors.<br />
1. <a href="/wiki/Presynaptic" title="Presynaptic" class="mw-redirect">Presynaptic</a> terminal<br />
2. <a href="/wiki/Sarcolemma" title="Sarcolemma">Sarcolemma</a><br />
3. <a href="/wiki/Synaptic_vesicle" title="Synaptic vesicle">Synaptic vesicle</a><br />
4. <a href="/wiki/Nicotinic_acetylcholine_receptor" title="Nicotinic acetylcholine receptor">Nicotinic acetylcholine receptor</a><br />
5. <a href="/wiki/Mitochondrion" title="Mitochondrion">Mitochondrion</a></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/G73.1">G73.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=358.1">358.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb4030.htm">4030</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000710.htm">000710</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic181.htm">neuro/181</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/emerg/topic292.htm#">emerg/292</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D015624">D015624</a></td>
</tr>
</table>
<p><b>Lambert–Eaton myasthenic syndrome</b> (<b>LEMS</b>, also <b>Lambert–Eaton syndrome</b>, or <b>Eaton–Lambert syndrome</b>) is a rare <a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a> disorder that is characterized by <a href="/wiki/Weakness" title="Weakness">muscle weakness</a> of the limbs. It is the result of an <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune reaction</a> in which <a href="/wiki/Antibody" title="Antibody">antibodies</a> are formed against presynaptic <a href="/wiki/Voltage-dependent_calcium_channel" title="Voltage-dependent calcium channel">voltage-gated calcium channels</a>, and likely other nerve terminal proteins, in the <a href="/wiki/Neuromuscular_junction" title="Neuromuscular junction">neuromuscular junction</a> (the connection between <a href="/wiki/Nerve" title="Nerve">nerves</a> and the <a href="/wiki/Muscle" title="Muscle">muscle</a> that they supply).<sup id="cite_ref-Mareska_1-0" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> The prevalence is 3.4 cases per million.<sup id="cite_ref-Titulaer_2-0" class="reference"><a href="#cite_note-Titulaer-2"><span>[</span>2<span>]</span></a></sup> Around 60% of those with LEMS have an underlying <a href="/wiki/Cancer" title="Cancer">malignancy</a>, most commonly <a href="/wiki/Small_cell_carcinoma" title="Small cell carcinoma" class="mw-redirect">small cell lung cancer</a>; it is therefore regarded as a <a href="/wiki/Paraneoplastic_syndrome" title="Paraneoplastic syndrome">paraneoplastic syndrome</a> (a condition that arises as a result of cancer elsewhere in the body).<sup id="cite_ref-Verschuuren_3-0" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup></p>
<p>People who develop LEMS are usually over 40, although it may occur at any age. The diagnosis is usually confirmed with <a href="/wiki/Electromyography" title="Electromyography">electromyography</a> and <a href="/wiki/Blood_test" title="Blood test">blood tests</a>; these also distinguish it from <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">myasthenia gravis</a> (MG), a related autoimmune neuromuscular disease.<sup id="cite_ref-Mareska_1-1" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>If the disease is associated with cancer, direct treatment of the cancer often relieves the symptoms of LEMS. Other treatments often used are <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a>, <a href="/wiki/Azathioprine" title="Azathioprine">azathioprine</a> and <a href="/wiki/Intravenous_immunoglobulin" title="Intravenous immunoglobulin">intravenous immunoglobulin</a>, which suppress the immune system, and <a href="/wiki/Pyridostigmine" title="Pyridostigmine">pyridostigmine</a> and <a href="/wiki/3,4-Diaminopyridine" title="3,4-Diaminopyridine">3,4-diaminopyridine</a>, which enhance the neuromuscular transmission. Occasionally, <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasma exchange</a> is required to remove the antibodies.<sup id="cite_ref-Mareska_1-2" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Mechanism"><span class="tocnumber">3</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#History"><span class="tocnumber">6</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The weakness of LEMS typically involves the legs and arms. Leg involvement is more striking than in <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">myasthenia gravis</a>. The proximal muscles (those closest to the trunk) are predominantly affected; this leads to difficulties climbing stairs and rising from a sitting position. <a href="/wiki/Physical_exercise" title="Physical exercise">Physical exercise</a> and high temperatures can worsen the symptoms. Weakness of the <a href="/wiki/Corticobulbar_tract" title="Corticobulbar tract">bulbar muscles</a> (supplying the mouth and throat) is occasionally encountered.<sup id="cite_ref-Mareska_1-3" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> Weakness of the <a href="/wiki/Muscles_of_orbit" title="Muscles of orbit" class="mw-redirect">eye muscles</a> is uncommon. Some may have <a href="/wiki/Diplopia" title="Diplopia">double vision</a>, <a href="/wiki/Ptosis_(eyelid)" title="Ptosis (eyelid)">drooping of the eyelids</a> and <a href="/wiki/Dysphagia" title="Dysphagia">difficulty swallowing</a>,<sup id="cite_ref-Mareska_1-4" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> but generally only together with leg weakness; this distinguishes LEMS from myasthenia gravis, in which eye signs are much more prominent.<sup id="cite_ref-Verschuuren_3-1" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> In the advanced stages of the disease, weakness of the <a href="/wiki/Muscles_of_respiration" title="Muscles of respiration">respiratory muscles</a> may occur.<sup id="cite_ref-Mareska_1-5" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> Some may also experience problems with <a href="/wiki/Motor_coordination" title="Motor coordination">coordination</a> (<a href="/wiki/Ataxia" title="Ataxia">ataxia</a>).<sup id="cite_ref-Rees_4-0" class="reference"><a href="#cite_note-Rees-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Three quarters of people with LEMS also have disruption of the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a>. This may be experienced as a <a href="/wiki/Xerostomia" title="Xerostomia">dry mouth</a>, <a href="/wiki/Constipation" title="Constipation">constipation</a>, <a href="/wiki/Blurred_vision" title="Blurred vision">blurred vision</a>, impaired <a href="/wiki/Perspiration" title="Perspiration">sweating</a>, and <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a> (falls in blood pressure on standing, potentially leading to <a href="/wiki/Syncope_(medicine)" title="Syncope (medicine)">blackouts</a>). Some report a metallic taste in the mouth.<sup id="cite_ref-Mareska_1-6" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>On <a href="/wiki/Neurological_examination" title="Neurological examination">neurological examination</a>, the weakness demonstrated with normal testing of power is often less severe than would be expected on the basis of the symptoms. Strength improves further with repeated testing, e.g. improvement of power on repeated hand grip (a phenomenon known as "Lambert's sign"). At rest, <a href="/wiki/Reflex" title="Reflex">reflexes</a> are typically reduced; with muscle use, reflex strength increases. This is a characteristic feature of LEMS. The <a href="/wiki/Pupillary_light_reflex" title="Pupillary light reflex">pupillary light reflex</a> may be sluggish.<sup id="cite_ref-Mareska_1-7" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>In LEMS associated with lung cancer, most have no suggestive symptoms of cancer at the time, such as <a href="/wiki/Cough" title="Cough">cough</a>, <a href="/wiki/Hemoptysis" title="Hemoptysis">coughing blood</a> and <a href="/wiki/Weight_loss#Unintentional_weight_loss" title="Weight loss">unintentional weight loss</a>.<sup id="cite_ref-Verschuuren_3-2" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> It has been suggested that LEMS associated with lung cancer is more severe.<sup id="cite_ref-Rees_4-1" class="reference"><a href="#cite_note-Rees-4"><span>[</span>4<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=2" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>LEMS is often associated with lung cancer (50–70%),<sup id="cite_ref-Mareska_1-8" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> making LEMS a <a href="/wiki/Paraneoplastic_syndrome" title="Paraneoplastic syndrome">paraneoplastic syndrome</a>.<sup id="cite_ref-Rees_4-2" class="reference"><a href="#cite_note-Rees-4"><span>[</span>4<span>]</span></a></sup> Of the people with small cell lung cancer, 1–3% have LEMS.<sup id="cite_ref-Verschuuren_3-3" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> In most of these cases, LEMS is the first symptom of the lung cancer, and it is otherwise <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a>.<sup id="cite_ref-Verschuuren_3-4" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup></p>
<p>LEMS may also be associated with <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a>, such as <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a> (an underactive <a href="/wiki/Thyroid_gland" title="Thyroid gland" class="mw-redirect">thyroid gland</a>) or <a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">diabetes mellitus type 1</a>.<sup id="cite_ref-Mareska_1-9" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Takamori_5-0" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> Myasthenia gravis, too, may happen in the presence of tumors (<a href="/wiki/Thymoma" title="Thymoma">thymoma</a>, a tumor of the <a href="/wiki/Thymus" title="Thymus">thymus</a> in the chest); people with MG without a tumor and people with LEMS without a tumor have similar genetic variations that seem to predispose them to these diseases.<sup id="cite_ref-Verschuuren_3-5" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> <a href="/wiki/HLA-DR3" title="HLA-DR3">HLA-DR3</a>-<a href="/wiki/HLA-B8" title="HLA-B8">B8</a> (an <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a> subtype), in particular, seems to predispose to LEMS.<sup id="cite_ref-Takamori_5-1" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism">Mechanism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=3" title="Edit section: Mechanism">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>In normal neuromuscular function, a <a href="/wiki/Action_potential" title="Action potential">nerve impulse</a> is carried down the <a href="/wiki/Axon" title="Axon">axon</a> (the long projection of a <a href="/wiki/Neuron" title="Neuron">nerve cell</a>) from the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>. At the nerve ending in the <a href="/wiki/Neuromuscular_junction" title="Neuromuscular junction">neuromuscular junction</a>, where the impulse is transferred to the muscle cell, the nerve impulse leads to the opening of <a href="/wiki/Voltage-gated_calcium_channels" title="Voltage-gated calcium channels" class="mw-redirect">voltage-gated calcium channels</a> (VGCC), the influx of calcium ions into the nerve terminal, and the calcium-dependent triggering of synaptic vesicle fusion with plasma membrane. These synaptic vesicles contain <a href="/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>, which is released into the synaptic cleft and stimulates the <a href="/wiki/Acetylcholine_receptor" title="Acetylcholine receptor">acetylcholine receptors</a> on the muscle. The muscle then contracts.<sup id="cite_ref-Mareska_1-10" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>In LEMS, antibodies against VGCC, particularly the <a href="/wiki/P-type_calcium_channel" title="P-type calcium channel">P</a>/<a href="/wiki/Q-type_calcium_channel" title="Q-type calcium channel">Q-type</a> VGCC, decrease the amount of calcium that can enter the nerve ending, hence less acetylcholine can be released from the neuromuscular junction. Apart from <a href="/wiki/Skeletal_muscle" title="Skeletal muscle" class="mw-redirect">skeletal muscle</a>, the autonomic nervous system also requires acetylcholine neurotransmission; this explains the occurrence of autonomic symptoms in LEMS.<sup id="cite_ref-Mareska_1-11" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Verschuuren_3-6" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> P/Q voltage-gated calcium channels are also found in the <a href="/wiki/Cerebellum" title="Cerebellum">cerebellum</a>, explaining why some experience problems with coordination.<sup id="cite_ref-Rees_4-3" class="reference"><a href="#cite_note-Rees-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Takamori_5-2" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> The antibodies bind particularly to the part of the receptor known as the "domain III S5–S6 linker peptide".<sup id="cite_ref-Takamori_5-3" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> Antibodies may also bind other VGCCs.<sup id="cite_ref-Takamori_5-4" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> Some patients have antibodies that bind <a href="/wiki/Synaptotagmin" title="Synaptotagmin" class="mw-redirect">synaptotagmin</a>, the protein sensor for calcium-regulated vesicle fusion.<sup id="cite_ref-Takamori_5-5" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> Many people with LEMS, both with and without VGCC antibodies, have detectable antibodies against the <a href="/wiki/Muscarinic_acetylcholine_receptor_M1" title="Muscarinic acetylcholine receptor M1">M1 subtype of the acetylcholine receptor</a>; it is thought that their presence participates in a lack of compensation for the weak calcium influx.<sup id="cite_ref-Takamori_5-6" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup></p>
<p>Apart from the decreased calcium influx, there is also a disruption of active zone vesicle release sites, which is also thought to be antibody-dependent since LEMS patients have antibodies to components of these active zones (including voltage-dependent calcium channels). Together, these abnormalities lead to the decrease in muscle contractility. Repeated stimuli over a period of about 10 seconds eventually lead to sufficient delivery of calcium, and an increase in muscle contraction to normal levels, which can be demonstrated using an <a href="/wiki/Electrodiagnostic_medicine" title="Electrodiagnostic medicine">electrodiagnostic medicine</a> study called needle electromyography by increasing amplitude of repeated <a href="/wiki/Compound_muscle_action_potential" title="Compound muscle action potential">compound muscle action potentials</a>.<sup id="cite_ref-Mareska_1-12" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>It has been shown that the antibodies found in LEMS associated with lung cancer also bind to calcium channels in the cancer cells, and it is presumed that the antibodies originally develop as a reaction to these cells.<sup id="cite_ref-Mareska_1-13" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> It has been suggested that the immune reaction to the cancer cells suppresses their growth and improves the prognosis from the cancer.<sup id="cite_ref-Verschuuren_3-7" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Takamori_5-7" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=4" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg/220px-Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg" width="220" height="208" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg/330px-Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg/440px-Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg 2x" data-file-width="1030" data-file-height="976" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Thorax_pa_peripheres_Bronchialcarcinom_li_OF_markiert.jpg" class="internal" title="Enlarge"></a></div>
Chest X-ray showing a tumor in the left lung (right side of the image)</div>
</div>
</div>
<p>The diagnosis is usually made on <a href="/wiki/Electromyography" title="Electromyography">electromyography</a> (EMG), which is one of the standard tests in the investigation of otherwise unexplained muscle weakness. This involves the insertion of small needles into the nerves supplying several muscles, administering small electrical impulses through these needles, and measuring the electrical response of the muscle in question. Two EMG investigations can be characteristic in LEMS: compound motor action potentials (CMAP) and single-fiber examination.<sup id="cite_ref-Mareska_1-14" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>CMAP shows small amplitudes but normal latency and conduction velocities. If repeated impulses are administered (two per second or 2&#160;Hz), it is normal for CMAP amplitudes to become smaller as the acetylcholine in the motor end plate is depleted. In LEMS, this decrease is larger than observed normally. Eventually, stored acetylcholine is made available, and the amplitudes increase again. In LEMS this remains insufficient to reach a level sufficient for transmission of an impulse from nerve to muscle; all can be attributed to insufficient calcium in the nerve terminal. A similar pattern is witnessed in myasthenia gravis. In LEMS, in response to exercising the muscle, the CMAP amplitude increases greatly (over 200%, often much more). This also occurs on the administration of a rapid burst of electrical stimuli (20 impulses per second for ten seconds). This is attributed to the influx of calcium in response to these stimuli.<sup id="cite_ref-Mareska_1-15" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Verschuuren_3-8" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> On single-fiber examination, features may include increased jitter (seen in other diseases of neuromuscular transmission) and blocking.<sup id="cite_ref-Mareska_1-16" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Blood tests may be performed to exclude other causes of muscle disease (elevated <a href="/wiki/Creatine_kinase" title="Creatine kinase">creatine kinase</a> may indicate a <a href="/wiki/Myositis" title="Myositis">myositis</a>, and abnormal <a href="/wiki/Thyroid_function_test" title="Thyroid function test" class="mw-redirect">thyroid function tests</a> may indicate <a href="/wiki/Thyrotoxic_myopathy" title="Thyrotoxic myopathy">thyrotoxic myopathy</a>). Antibodies against voltage-gated calcium channels can be identified in 85% of people with EMG confirmed LEMS.<sup id="cite_ref-Mareska_1-17" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> Once LEMS is diagnosed, investigations such as a <a href="/wiki/X-ray_computed_tomography" title="X-ray computed tomography" class="mw-redirect">CT scan</a> of the chest are usually performed to identify any possible underlying lung tumors. 50–60% of these are discovered immediately after the diagnosis of LEMS. The remainder is diagnosed later, but usually within two years and typically within four years.<sup id="cite_ref-Verschuuren_3-9" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> As a result, scans are typically repeated every six months for the first two years after diagnosis.<sup id="cite_ref-Mareska_1-18" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> While CT of the lungs is usually adequate, a <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a> (PET) scan of the body may also be performed to search for an occult tumour, particularly of the lung.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=5" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diaminopyridine.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b1/Diaminopyridine.png/220px-Diaminopyridine.png" width="220" height="210" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b1/Diaminopyridine.png/330px-Diaminopyridine.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b1/Diaminopyridine.png/440px-Diaminopyridine.png 2x" data-file-width="895" data-file-height="856" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diaminopyridine.png" class="internal" title="Enlarge"></a></div>
Molecular structure of 3,4-diaminopyridine, a commonly used drug treatment for LEMS.</div>
</div>
</div>
<p>If LEMS is caused by an underlying cancer, treatment of the malignancy usually leads to resolution of the symptoms.<sup id="cite_ref-Mareska_1-19" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> Treatment usually consists of <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, with <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> in those with limited disease.<sup id="cite_ref-Verschuuren_3-10" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Three treatment modalities aimed at improving LEMS symptoms directly, namely pyridostigmine, <a href="/wiki/3,4-diaminopyridine" title="3,4-diaminopyridine" class="mw-redirect">3,4-diaminopyridine</a> (amifampridine) and <a href="/wiki/Guanidine" title="Guanidine">guanidine</a>, work to improve neuromuscular transmission. Pyridostigmine decreases the degradation of acetylcholine after release into the synaptic cleft, and thereby improves muscle contraction. In LEMS, the <a href="/wiki/Potassium_channel" title="Potassium channel">potassium channel</a> blocker 3,4-diaminopyridine base or the water-soluble formulation, 3,4-diaminopyridine phosphate, (marketed under the name Firdapse) are also used.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> Both 3,4-diaminopyridine formulations delay the repolarization of nerve terminals after a discharge, thereby allowing more calcium to accumulate in the nerve terminal.<sup id="cite_ref-Mareska_1-20" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Verschuuren_3-11" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup> In the United States, 3,4-diaminopyridine phosphate (Firdapse) a more stable formulation of 3,4-diaminopyridine that does not require refrigeration<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-EMAreport_9-0" class="reference"><a href="#cite_note-EMAreport-9"><span>[</span>9<span>]</span></a></sup> and 3.4-diaminopyridine free base are undergoing clinical trials to treat LEMS. Pending completion of these trials and submission to the FDA, both formulations are available to LEMS patients in the U.S.: the free base is available under a compassionate distribution program by Jacobus Pharmaceutical Company, and the phosphate salt is available to LEMS patients under an expanded access program by <a href="/w/index.php?title=Catalyst_Pharmaceuticals&amp;action=edit&amp;redlink=1" class="new" title="Catalyst Pharmaceuticals (page does not exist)">Catalyst Pharmaceuticals</a>. Compounding pharmacies may also be a source of 3,4-diaminopyridine salts in the U.S. In Europe, 3,4-diaminopyridine phosphate is sold by BioMarin under the name Firdapse, and the free base is compounded, usually by hospital pharmacies. An older agent, <a href="/wiki/Guanidine" title="Guanidine">guanidine</a>, causes many side-effects and is not recommended. <a href="/wiki/4-Aminopyridine" title="4-Aminopyridine">4-Aminopyridine</a> (dalfampridine), an agent related to 3,4-aminopyridine, causes more side-effects than 3,4-DAP and is also not recommended.<sup id="cite_ref-Verschuuren_3-12" class="reference"><a href="#cite_note-Verschuuren-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Immune suppression tends to be less effective than in other autoimmune diseases. Prednisolone (a glucocorticoid or steroid) suppresses the immune response, and the steroid-sparing agent azathioprine may replace it once therapeutic effect has been achieved. <a href="/wiki/Intravenous_immunoglobulin" title="Intravenous immunoglobulin">Intravenous immunoglobulin</a> (IVIG) may be used with a degree of effectiveness. Plasma exchange (or plasmapheresis), the removal of plasma proteins such as antibodies and replacement with normal plasma, may provide improvement in acute severe weakness. Again, plasma exchange is less effective than in other related conditions such as myasthenia gravis, and additional immunosuppressive medication is often needed.<sup id="cite_ref-Mareska_1-21" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup> According to a systematic review by the <a href="/wiki/Cochrane_Collaboration" title="Cochrane Collaboration">Cochrane Collaboration</a>, the best evidence in the treatment of LEMS exists for 3,4-aminopyridine and IVIG.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=6" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Anderson and colleagues from <a href="/wiki/St_Thomas%27_Hospital" title="St Thomas' Hospital">St Thomas' Hospital</a>, London, were the first to mention a case with possible clinical findings of LEMS in 1953,<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> but Lambert, Eaton and Rooke at the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a> were the first physicians to substantially describe the clinical and electrophysiological findings of the disease in 1956.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> In 1972, the clustering of LEMS with other autoimmune diseases led to the hypothesis that it was caused by autoimmunity.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> Studies in the 1980s confirmed the autoimmune nature,<sup id="cite_ref-Takamori_5-8" class="reference"><a href="#cite_note-Takamori-5"><span>[</span>5<span>]</span></a></sup> and research in the 1990s demonstrated the link with antibodies against P/Q-type voltage-gated calcium channels.<sup id="cite_ref-Mareska_1-22" class="reference"><a href="#cite_note-Mareska-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit&amp;section=7" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 28em; -webkit-column-width: 28em; column-width: 28em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Mareska-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mareska_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mareska_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mareska_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Mareska_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Mareska_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Mareska_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Mareska_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Mareska_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Mareska_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Mareska_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Mareska_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Mareska_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Mareska_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Mareska_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Mareska_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Mareska_1-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Mareska_1-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Mareska_1-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Mareska_1-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Mareska_1-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Mareska_1-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Mareska_1-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Mareska_1-22"><sup><i><b>w</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Mareska M, Gutmann L (June 2004). "Lambert–Eaton myasthenic syndrome". <i>Semin. Neurol.</i> <b>24</b> (2): 149–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2004-830900">10.1055/s-2004-830900</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15257511">15257511</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.aulast=Mareska+M%2C+Gutmann+L&amp;rft.au=Mareska+M%2C+Gutmann+L&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2004-830900&amp;rft_id=info%3Apmid%2F15257511&amp;rft.issue=2&amp;rft.jtitle=Semin.+Neurol.&amp;rft.pages=149-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Titulaer-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-Titulaer_2-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Titulaer MJ, Lang B, Verschuuren JJ (December 2011). "Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies". <i>Lancet Neurol</i> <b>10</b> (12): 1098–107. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1474-4422%2811%2970245-9">10.1016/S1474-4422(11)70245-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22094130">22094130</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Lambert%E2%80%93Eaton+myasthenic+syndrome%3A+from+clinical+characteristics+to+therapeutic+strategies&amp;rft.aulast=Titulaer+MJ%2C+Lang+B%2C+Verschuuren+JJ&amp;rft.au=Titulaer+MJ%2C+Lang+B%2C+Verschuuren+JJ&amp;rft.date=December+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2811%2970245-9&amp;rft_id=info%3Apmid%2F22094130&amp;rft.issue=12&amp;rft.jtitle=Lancet+Neurol&amp;rft.pages=1098-107&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Verschuuren-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Verschuuren_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Verschuuren_3-12"><sup><i><b>m</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Verschuuren JJ, Wirtz PW, Titulaer MJ, Willems LN, van Gerven J (July 2006). "Available treatment options for the management of Lambert–Eaton myasthenic syndrome". <i>Expert Opin. Pharmacother.</i> <b>7</b> (10): 1323–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1517%2F14656566.7.10.1323">10.1517/14656566.7.10.1323</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16805718">16805718</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Available+treatment+options+for+the+management+of+Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.aulast=Verschuuren+JJ%2C+Wirtz+PW%2C+Titulaer+MJ%2C+Willems+LN%2C+van+Gerven+J&amp;rft.au=Verschuuren+JJ%2C+Wirtz+PW%2C+Titulaer+MJ%2C+Willems+LN%2C+van+Gerven+J&amp;rft.date=July+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1517%2F14656566.7.10.1323&amp;rft_id=info%3Apmid%2F16805718&amp;rft.issue=10&amp;rft.jtitle=Expert+Opin.+Pharmacother.&amp;rft.pages=1323-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rees-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rees_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rees_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rees_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rees_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rees JH (June 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1765657">"Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage"</a>. <i>J. Neurol. Neurosurg. Psychiatr</i>. 75 Suppl 2 (Suppl 2): ii43–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjnnp.2004.040378">10.1136/jnnp.2004.040378</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1765657">1765657</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15146039">15146039</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Paraneoplastic+syndromes%3A+when+to+suspect%2C+how+to+confirm%2C+and+how+to+manage&amp;rft.aulast=Rees+JH&amp;rft.au=Rees+JH&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1765657&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2004.040378&amp;rft_id=info%3Apmc%2F1765657&amp;rft_id=info%3Apmid%2F15146039&amp;rft.issue=Suppl+2&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.pages=ii43-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75+Suppl+2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Takamori-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Takamori_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Takamori_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Takamori_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Takamori_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Takamori_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Takamori_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Takamori_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Takamori_5-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Takamori_5-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Takamori M (September 2008). "Lambert–Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis". <i>J. Neuroimmunol</i>. 201-202: 145–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jneuroim.2008.04.040">10.1016/j.jneuroim.2008.04.040</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18653248">18653248</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Lambert%E2%80%93Eaton+myasthenic+syndrome%3A+search+for+alternative+autoimmune+targets+and+possible+compensatory+mechanisms+based+on+presynaptic+calcium+homeostasis&amp;rft.aulast=Takamori+M&amp;rft.au=Takamori+M&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jneuroim.2008.04.040&amp;rft_id=info%3Apmid%2F18653248&amp;rft.jtitle=J.+Neuroimmunol.&amp;rft.pages=145-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=201-202" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation book">Ropper AH, Brown RH (2005). "53". In Ropper AH, Brown RH. <i>Adams and Victor's Principles of Neurology</i> (8th ed.). New York: McGraw-Hill Professional. p.&#160;1261. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1036%2F0071469710">10.1036/0071469710</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-07-141620-X" title="Special:BookSources/0-07-141620-X">0-07-141620-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=53&amp;rft.aulast=Ropper+AH%2C+Brown+RH&amp;rft.au=Ropper+AH%2C+Brown+RH&amp;rft.btitle=Adams+and+Victor%27s+Principles+of+Neurology&amp;rft.date=2005&amp;rft.edition=8th&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1036%2F0071469710&amp;rft.isbn=0-07-141620-X&amp;rft.pages=1261&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill+Professional&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Lindquist, S; Stangel, M; Ullah, I (2011). "Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.". <i>Neuropsychiatric disease and treatment</i> <b>7</b>: 341–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2147%2FNDT.S10464">10.2147/NDT.S10464</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21822385">21822385</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Update+on+treatment+options+for+Lambert-Eaton+myasthenic+syndrome%3A+focus+on+use+of+amifampridine.&amp;rft.aufirst=S&amp;rft.aulast=Lindquist&amp;rft.au=Lindquist%2C+S&amp;rft.au=Stangel%2C+M&amp;rft.au=Ullah%2C+I&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2147%2FNDT.S10464&amp;rft_id=info%3Apmid%2F21822385&amp;rft.jtitle=Neuropsychiatric+disease+and+treatment&amp;rft.pages=341-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Raust, JA et al. (2007). "Stability studies of ionised and non-ionised 3,4-diaminopyridine: hypothesis of degradation pathways and chemical structure of degradation products.". <i>J Pharm Biomed Anal</i>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16844337">16844337</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Stability+studies+of+ionised+and+non-ionised+3%2C4-diaminopyridine%3A+hypothesis+of+degradation+pathways+and+chemical+structure+of+degradation+products.&amp;rft.aufirst=JA&amp;rft.aulast=Raust&amp;rft.au=Raust%2C+JA&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F16844337&amp;rft.jtitle=J+Pharm+Biomed+Anal.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-EMAreport-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-EMAreport_9-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001032/WC500069918.pdf">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001032/WC500069918.pdf</a></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Maddison P, Newsom-Davis J (2005). Maddison, Paul, ed. <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD003279/frame.html">"Treatment for Lambert–Eaton myasthenic syndrome"</a>. <i>Cochrane Database of Systematic Reviews</i> (2): CD003279. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD003279.pub2">10.1002/14651858.CD003279.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15846654">15846654</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Treatment+for+Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.aulast=Maddison+P%2C+Newsom-Davis+J&amp;rft.au=Maddison+P%2C+Newsom-Davis+J&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fo%2Fcochrane%2Fclsysrev%2Farticles%2FCD003279%2Fframe.html&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003279.pub2&amp;rft_id=info%3Apmid%2F15846654&amp;rft.issue=2&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=CD003279&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Anderson HJ, Churchill-Davidson HC, Richardson AT (December 1953). "Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine". <i>Lancet</i> <b>265</b> (6799): 1291–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2853%2991358-0">10.1016/S0140-6736(53)91358-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13110148">13110148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Bronchial+neoplasm+with+myasthenia%3B+prolonged+apnoea+after+administration+of+succinylcholine&amp;rft.au=Anderson+HJ%2C+Churchill-Davidson+HC%2C+Richardson+AT&amp;rft.aulast=Anderson+HJ%2C+Churchill-Davidson+HC%2C+Richardson+AT&amp;rft.date=December+1953&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2853%2991358-0&amp;rft_id=info%3Apmid%2F13110148&amp;rft.issue=6799&amp;rft.jtitle=Lancet&amp;rft.pages=1291-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=265" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><i><a rel="nofollow" class="external text" href="http://www.whonamedit.com/synd.cfm/2738.html">Lambert-Eaton-Rooke syndrome</a></i> at <a href="/wiki/Who_Named_It%3F" title="Who Named It?" class="mw-redirect">Who Named It?</a></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Lambert EH, Eaton LM, Rooke ED (1956). "Defect of neuromuscular conduction associated with malignant neoplasms". <i>Am. J. Physiol.</i> <b>187</b>: 612–613.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Defect+of+neuromuscular+conduction+associated+with+malignant+neoplasms&amp;rft.au=Lambert+EH%2C+Eaton+LM%2C+Rooke+ED&amp;rft.aulast=Lambert+EH%2C+Eaton+LM%2C+Rooke+ED&amp;rft.date=1956&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Physiol.&amp;rft.pages=612-613&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=187" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Gutmann L, Crosby TW, Takamori M, Martin JD (September 1972). "The Eaton–Lambert syndrome and autoimmune disorders". <i>Am. J. Med.</i> <b>53</b> (3): 354–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0002-9343%2872%2990179-9">10.1016/0002-9343(72)90179-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4115499">4115499</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=The+Eaton%E2%80%93Lambert+syndrome+and+autoimmune+disorders&amp;rft.au=Gutmann+L%2C+Crosby+TW%2C+Takamori+M%2C+Martin+JD&amp;rft.aulast=Gutmann+L%2C+Crosby+TW%2C+Takamori+M%2C+Martin+JD&amp;rft.date=September+1972&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0002-9343%2872%2990179-9&amp;rft_id=info%3Apmid%2F4115499&amp;rft.issue=3&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=354-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Motomura M, Hamasaki S, Nakane S, Fukuda T, Nakao YK (August 2000). "Apheresis treatment in Lambert–Eaton myasthenic syndrome". <i>Ther. Apher.</i> <b>4</b> (4): 287–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1526-0968.2000.004004287.x">10.1046/j.1526-0968.2000.004004287.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10975475">10975475</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.atitle=Apheresis+treatment+in+Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;rft.aulast=Motomura+M%2C+Hamasaki+S%2C+Nakane+S%2C+Fukuda+T%2C+Nakao+YK&amp;rft.au=Motomura+M%2C+Hamasaki+S%2C+Nakane+S%2C+Fukuda+T%2C+Nakao+YK&amp;rft.date=August+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1526-0968.2000.004004287.x&amp;rft_id=info%3Apmid%2F10975475&amp;rft.issue=4&amp;rft.jtitle=Ther.+Apher.&amp;rft.pages=287-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Diseases_of_myoneural_junction_and_muscle" title="Template:Diseases of myoneural junction and muscle"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Diseases_of_myoneural_junction_and_muscle" title="Template talk:Diseases of myoneural junction and muscle"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Diseases_of_myoneural_junction_and_muscle&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Diseases of <a href="/wiki/Myoneural_junction" title="Myoneural junction" class="mw-redirect">myoneural junction</a> and <a href="/wiki/Muscle" title="Muscle">muscle</a> / <a href="/wiki/Neuromuscular_disease" title="Neuromuscular disease">neuromuscular disease</a> (<a href="/wiki/ICD-10_Chapter_VI:_Diseases_of_the_nervous_system#.28G70.E2.80.93G73.29_Diseases_of_myoneural_junction_and_muscle" title="ICD-10 Chapter VI: Diseases of the nervous system">G70–G73</a>, <a href="/wiki/List_of_ICD-9_codes_320%E2%80%93359:_diseases_of_the_nervous_system#Disorders_of_the_peripheral_nervous_system_.28350.E2.80.93359.29" title="List of ICD-9 codes 320–359: diseases of the nervous system">358–359</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Neuromuscular_junction_disease" title="Neuromuscular junction disease">Neuromuscular-</a><br />
<a href="/wiki/Neuromuscular_junction_disease" title="Neuromuscular junction disease">junction disease</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a></i>
<ul>
<li><a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></li>
<li><strong class="selflink">Lambert–Eaton myasthenic syndrome</strong></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myopathy" title="Myopathy">Myopathy</a>/<br />
<a href="/wiki/Congenital_myopathy" title="Congenital myopathy">congenital myopathy</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Muscular_dystrophy" title="Muscular dystrophy">Muscular dystrophy</a><br />
(<a href="/wiki/Dystrophin-associated_protein_complex" title="Dystrophin-associated protein complex">DAPC</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">AD</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Limb-girdle_muscular_dystrophy" title="Limb-girdle muscular dystrophy">Limb-girdle muscular dystrophy 1</a></li>
<li><a href="/wiki/Oculopharyngeal_muscular_dystrophy" title="Oculopharyngeal muscular dystrophy">Oculopharyngeal</a></li>
<li><a href="/wiki/Facioscapulohumeral_muscular_dystrophy" title="Facioscapulohumeral muscular dystrophy">Facioscapulohumeral</a></li>
<li><a href="/wiki/Myotonic_dystrophy" title="Myotonic dystrophy">Myotonic</a></li>
<li><a href="/wiki/Distal_muscular_dystrophy" title="Distal muscular dystrophy">Distal (most)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">AR</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Limb-girdle_muscular_dystrophy" title="Limb-girdle muscular dystrophy">Limb-girdle muscular dystrophy 2</a></li>
<li><a href="/wiki/Congenital_muscular_dystrophy" title="Congenital muscular dystrophy">Congenital</a>
<ul>
<li><a href="/wiki/Fukuyama_congenital_muscular_dystrophy" title="Fukuyama congenital muscular dystrophy">Fukuyama</a></li>
<li><a href="/wiki/Ullrich_congenital_muscular_dystrophy" title="Ullrich congenital muscular dystrophy">Ullrich</a></li>
<li><a href="/wiki/Walker%E2%80%93Warburg_syndrome" title="Walker–Warburg syndrome">Walker–Warburg</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/X-linked_recessive" title="X-linked recessive" class="mw-redirect">XR</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Dystrophin" title="Dystrophin">dystrophin</a></i>
<ul>
<li><a href="/wiki/Becker%27s_muscular_dystrophy" title="Becker's muscular dystrophy">Becker's</a></li>
<li><a href="/wiki/Duchenne_muscular_dystrophy" title="Duchenne muscular dystrophy">Duchenne</a></li>
</ul>
</li>
<li><a href="/wiki/Emery%E2%80%93Dreifuss_muscular_dystrophy" title="Emery–Dreifuss muscular dystrophy">Emery–Dreifuss</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other structural</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Collagen_disease" title="Collagen disease">collagen disease</a></i>
<ul>
<li><a href="/wiki/Bethlem_myopathy" title="Bethlem myopathy">Bethlem myopathy</a></li>
</ul>
</li>
<li><i><a href="/wiki/Protein_tyrosine_phosphatase" title="Protein tyrosine phosphatase">PTP disease</a></i>
<ul>
<li><a href="/wiki/X-linked_myotubular_myopathy" title="X-linked myotubular myopathy">X-linked MTM</a></li>
</ul>
</li>
<li><i><a href="/wiki/Adaptor_protein" title="Adaptor protein" class="mw-redirect">adaptor protein disease</a></i>
<ul>
<li><a href="/wiki/Centronuclear_myopathy" title="Centronuclear myopathy">BIN1-linked centronuclear myopathy</a></li>
</ul>
</li>
<li><i><a href="/wiki/Cytoskeleton" title="Cytoskeleton">cytoskeleton disease</a></i>
<ul>
<li><a href="/wiki/Nemaline_myopathy" title="Nemaline myopathy">Nemaline myopathy</a></li>
<li><a href="/wiki/Zaspopathy" title="Zaspopathy">Zaspopathy</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Channelopathy" title="Channelopathy">Channelopathy</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myotonia" title="Myotonia">Myotonia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Myotonia_congenita" title="Myotonia congenita">Myotonia congenita</a></li>
<li><a href="/wiki/Thomsen_disease" title="Thomsen disease" class="mw-redirect">Thomsen disease</a></li>
<li><a href="/wiki/Neuromyotonia" title="Neuromyotonia">Neuromyotonia</a>/<a href="/wiki/Isaacs_syndrome" title="Isaacs syndrome" class="mw-redirect">Isaacs syndrome</a></li>
<li><a href="/wiki/Paramyotonia_congenita" title="Paramyotonia congenita">Paramyotonia congenita</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Periodic_paralysis" title="Periodic paralysis">Periodic paralysis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypokalemic_periodic_paralysis" title="Hypokalemic periodic paralysis">Hypokalemic</a>
<ul>
<li><a href="/wiki/Thyrotoxic_periodic_paralysis" title="Thyrotoxic periodic paralysis">Thyrotoxic</a></li>
</ul>
</li>
<li><a href="/wiki/Hyperkalemic_periodic_paralysis" title="Hyperkalemic periodic paralysis">Hyperkalemic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Central_core_disease" title="Central core disease">Central core disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mitochondrial_myopathy" title="Mitochondrial myopathy">Mitochondrial myopathy</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mitochondrial_encephalomyopathy,_lactic_acidosis,_and_stroke-like_episodes" title="Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes" class="mw-redirect">MELAS</a></li>
<li><a href="/wiki/MERRF_syndrome" title="MERRF syndrome">MERRF</a></li>
<li><a href="/wiki/Kearns-Sayre_syndrome" title="Kearns-Sayre syndrome" class="mw-redirect">KSS</a></li>
<li><a href="/wiki/Progressive_external_ophthalmoplegia" title="Progressive external ophthalmoplegia" class="mw-redirect">PEO</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Inflammatory_myopathy" title="Inflammatory myopathy">Inflammatory myopathy</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Muscle_navs" title="Template:Muscle navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Muscle_navs" title="Template talk:Muscle navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Muscle_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Muscle" title="Muscle">muscle</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Muscular_system" title="Template:Muscular system">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Muscles_of_head" title="Template:Muscles of head">head</a></li>
<li><a href="/wiki/Template:Muscles_of_neck" title="Template:Muscles of neck">neck</a></li>
<li><a href="/wiki/Template:Muscles_of_upper_limb" title="Template:Muscles of upper limb">arms</a></li>
<li><a href="/wiki/Template:Muscles_of_thorax_and_back" title="Template:Muscles of thorax and back">chest and back</a></li>
<li><a href="/wiki/Template:Thoracic_diaphragm" title="Template:Thoracic diaphragm">diaphragm</a></li>
<li><a href="/wiki/Template:Muscles_of_abdomen" title="Template:Muscles of abdomen">abdomen</a></li>
<li><a href="/wiki/Template:Muscles_of_perineum" title="Template:Muscles of perineum">genital area</a></li>
<li><a href="/wiki/Template:Muscles_of_lower_limb" title="Template:Muscles of lower limb">legs</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Muscle_tissue" title="Template:Muscle tissue">Muscle tissue</a></li>
<li><a href="/wiki/Template:Muscular_physiology" title="Template:Muscular physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Connective_tissue" title="Template:Connective tissue">connective tissue</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myopathy" title="Template:Myopathy">Myopathy</a></li>
<li><a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">Soft tissue</a></li>
<li><a href="/wiki/Template:Systemic_connective_tissue_disorders" title="Template:Systemic connective tissue disorders">Connective tissue</a></li>
<li><a href="/wiki/Template:Diseases_of_myoneural_junction_and_muscle" title="Template:Diseases of myoneural junction and muscle">Congenital</a>
<ul>
<li><a href="/wiki/Template:Congenital_diaphragm_and_abdominal_wall_defects" title="Template:Congenital diaphragm and abdominal wall defects">abdomen</a></li>
<li><a href="/wiki/Template:Muscular_dystrophy" title="Template:Muscular dystrophy">muscular dystrophy</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Soft_tissue_tumors_and_sarcomas" title="Template:Soft tissue tumors and sarcomas">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">Injury</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_muscles_and_soft_tissue" title="Template:Eponymous medical signs for muscles and soft tissue">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Muscle_and_soft_tissue_procedures" title="Template:Muscle and soft tissue procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Anti-inflammatory_products" title="Template:Anti-inflammatory products">anti-inflammatory</a></li>
<li><a href="/wiki/Template:Muscle_relaxants" title="Template:Muscle relaxants">muscle relaxants</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Paraneoplastic_syndromes" title="Template:Paraneoplastic syndromes"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Paraneoplastic_syndromes" title="Template talk:Paraneoplastic syndromes"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Paraneoplastic_syndromes&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Paraneoplastic_syndrome" title="Paraneoplastic syndrome">Paraneoplastic syndromes</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Endocrine_system" title="Endocrine system">Endocrine</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypercalcaemia" title="Hypercalcaemia">Hypercalcaemia</a></li>
<li><a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone_secretion" title="Syndrome of inappropriate antidiuretic hormone secretion">SIADH</a></li>
<li><a href="/wiki/Zollinger%E2%80%93Ellison_syndrome" title="Zollinger–Ellison syndrome">Zollinger–Ellison syndrome</a></li>
<li><a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">Cushing's syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Blood" title="Blood">Hematological</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Granulocytosis" title="Granulocytosis">Granulocytosis</a></li>
<li><a href="/wiki/Multicentric_reticulohistiocytosis" title="Multicentric reticulohistiocytosis">Multicentric reticulohistiocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Neurology" title="Neurology">Neurological</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Paraneoplastic_cerebellar_degeneration" title="Paraneoplastic cerebellar degeneration">Paraneoplastic cerebellar degeneration</a></li>
<li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Opsoclonus" title="Opsoclonus">Opsoclonus</a></li>
<li><a href="/wiki/Polymyositis" title="Polymyositis">Polymyositis</a></li>
<li><a href="/wiki/Transverse_myelitis" title="Transverse myelitis">Transverse myelitis</a></li>
<li><strong class="selflink">Lambert–Eaton myasthenic syndrome</strong></li>
<li><a href="/wiki/Anti-NMDA_receptor_encephalitis" title="Anti-NMDA receptor encephalitis">Anti-NMDA receptor encephalitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Human_musculoskeletal_system" title="Human musculoskeletal system">Musculoskeletal</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Dermatomyositis" title="Dermatomyositis">Dermatomyositis</a></li>
<li><a href="/wiki/Hypertrophic_osteopathy" title="Hypertrophic osteopathy">Hypertrophic osteopathy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mucocutaneous_zone" title="Mucocutaneous zone">Mucocutaneous</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">reactive <a href="/wiki/Erythema" title="Erythema">erythema</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Erythema_gyratum_repens" title="Erythema gyratum repens">Erythema gyratum repens</a></li>
<li><a href="/wiki/Necrolytic_migratory_erythema" title="Necrolytic migratory erythema">Necrolytic migratory erythema</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Papulosquamous_disorder" title="Papulosquamous disorder">papulosquamous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acanthosis_nigricans" title="Acanthosis nigricans">Acanthosis nigricans</a></li>
<li><a href="/wiki/Ichthyosis_acquisita" title="Ichthyosis acquisita">Ichthyosis acquisita</a></li>
<li><a href="/wiki/Acrokeratosis_paraneoplastica_of_Bazex" title="Acrokeratosis paraneoplastica of Bazex">Acrokeratosis paraneoplastica of Bazex</a></li>
<li><a href="/wiki/Extramammary_Paget%27s_disease" title="Extramammary Paget's disease">Extramammary Paget's disease</a></li>
<li><a href="/wiki/Florid_cutaneous_papillomatosis" title="Florid cutaneous papillomatosis">Florid cutaneous papillomatosis</a></li>
<li><a href="/wiki/Leser%E2%80%93Tr%C3%A9lat_sign" title="Leser–Trélat sign">Leser-Trélat sign</a></li>
<li><a href="/wiki/Pityriasis_rotunda" title="Pityriasis rotunda">Pityriasis rotunda</a></li>
<li><a href="/wiki/Tripe_palms" title="Tripe palms">Tripe palms</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Febrile_neutrophilic_dermatosis" title="Febrile neutrophilic dermatosis">Febrile neutrophilic dermatosis</a></li>
<li><a href="/wiki/Pyoderma_gangrenosum" title="Pyoderma gangrenosum">Pyoderma gangrenosum</a></li>
<li><a href="/wiki/Paraneoplastic_pemphigus" title="Paraneoplastic pemphigus">Paraneoplastic pemphigus</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Neoplasia_navs" title="Template:Neoplasia navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Neoplasia_navs" title="Template talk:Neoplasia navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Neoplasia_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Neoplasm" title="Neoplasm">neoplasms</a> and <a href="/wiki/Cancer" title="Cancer">cancer</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Tumor_suppressor_genes_and_oncogenes" title="Template:Tumor suppressor genes and oncogenes">Tumor suppressing and oncogenes</a></li>
<li><a href="/wiki/Template:Tumor_markers" title="Template:Tumor markers">Tumor markers</a></li>
<li><a href="/wiki/Template:Carcinogen" title="Template:Carcinogen">Carcinogen</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Tumors" title="Template:Tumors">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_oncology" title="Template:Eponymous medical signs for oncology">Symptoms and signs</a></li>
<li><a href="/wiki/Template:Paraneoplastic_syndromes" title="Template:Paraneoplastic syndromes">Paraneoplastic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Radiation_oncology" title="Template:Radiation oncology">Radiotherapy</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Monoclonals_for_tumors" title="Template:Monoclonals for tumors">Immunotherapy</a></li>
<li><a href="/wiki/Template:Intracellular_chemotherapeutic_agents" title="Template:Intracellular chemotherapeutic agents">intracellular chemotherapeutics</a></li>
<li><a href="/wiki/Template:Extracellular_chemotherapeutic_agents" title="Template:Extracellular chemotherapeutic agents">extracellular chemotherapeutics</a></li>
<li><a href="/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment" title="Template:Detoxifying agents for antineoplastic treatment">adjuvant detoxification</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1194
CPU time usage: 0.396 seconds
Real time usage: 0.457 seconds
Preprocessor visited node count: 2162/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 119770/2097152 bytes
Template argument size: 1014/2097152 bytes
Highest expansion depth: 10/40
Expensive parser function count: 0/500
Lua time usage: 0.124/10.000 seconds
Lua memory usage: 3.14 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  354.806      1 - -total
 31.91%  113.212      1 - Template:Reflist
 28.16%   99.916      8 - Template:Navbox
 18.74%   66.507     12 - Template:Cite_journal
 18.47%   65.536      1 - Template:Good_article
 17.81%   63.206      1 - Template:Top_icon
 17.37%   61.626      1 - Template:Infobox_disease
 14.94%   53.001      1 - Template:Infobox
 11.81%   41.892      1 - Template:Diseases_of_myoneural_junction_and_muscle
 10.12%   35.924      1 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:18628-0!*!0!!en!4!* and timestamp 20150711014722 and revision id 668464507
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Lambert–Eaton_myasthenic_syndrome&amp;oldid=668464507">https://en.wikipedia.org/w/index.php?title=Lambert–Eaton_myasthenic_syndrome&amp;oldid=668464507</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Myoneural_junction_and_neuromuscular_diseases" title="Category:Myoneural junction and neuromuscular diseases">Myoneural junction and neuromuscular diseases</a></li><li><a href="/wiki/Category:Paraneoplastic_syndromes" title="Category:Paraneoplastic syndromes">Paraneoplastic syndromes</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Lambert%E2%80%93Eaton+myasthenic+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Lambert%E2%80%93Eaton_myasthenic_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Lambert%E2%80%93Eaton_myasthenic_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Lambert%E2%80%93Eaton_myasthenic_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;oldid=668464507" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1756898" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;id=668464507" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Lambert%E2%80%93Eaton+myasthenic+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Lambert%E2%80%93Eaton+myasthenic+syndrome&amp;oldid=668464507&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D9%84%D8%A7%D9%85%D8%A8%D8%B1%D8%AA-%D8%A5%D9%8A%D8%AA%D9%88%D9%86" title="متلازمة لامبرت-إيتون – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/S%C3%ADndrome_de_Lambert-Eaton" title="Síndrome de Lambert-Eaton – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Lambert-Eaton-Rooke-Syndrom" title="Lambert-Eaton-Rooke-Syndrom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/S%C3%ADndrome_miast%C3%A9nico_de_Lambert-Eaton" title="Síndrome miasténico de Lambert-Eaton – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Syndrome_myasth%C3%A9nique_de_Lambert-Eaton" title="Syndrome myasthénique de Lambert-Eaton – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Sindrome_di_Lambert-Eaton" title="Sindrome di Lambert-Eaton – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Syndroom_van_Lambert-Eaton" title="Syndroom van Lambert-Eaton – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%A9%E3%83%B3%E3%83%90%E3%83%BC%E3%83%88%E3%83%BB%E3%82%A4%E3%83%BC%E3%83%88%E3%83%B3%E7%97%87%E5%80%99%E7%BE%A4" title="ランバート・イートン症候群 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_Lamberta-Eatona" title="Zespół Lamberta-Eatona – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/S%C3%ADndrome_miast%C3%AAnica_de_Lambert-Eaton" title="Síndrome miastênica de Lambert-Eaton – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Lambert%E2%80%93Itonov_mijasteni%C4%8Dni_sindrom" title="Lambert–Itonov mijastenični sindrom – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1756898#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 24 June 2015, at 13:20.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Lambert%E2%80%93Eaton_myasthenic_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":112,"wgHostname":"mw1098"});
}</script>
	</body>
</html>
